• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

A new resorbable magnesium scaffold (DREAMS 3G): 12-month vasomotion results from the BIOMAG-I first-in-human study.

作者信息

Haude Michael, Iglesias Juan F, Garcia-Garcia Hector M, Barlagiannis Dimitrios, Degrauwe Sophie, Melaku Gebremedhin, Beyene Solomon, Waksman Ron

机构信息

Medical Clinic I, Rheinland Klinikum Neuss GmbH, Lukaskrankenhaus, Neuss, Germany.

Department of Cardiology, Geneva University Hospitals, Geneva, Switzerland.

出版信息

EuroIntervention. 2024 Sep 2;20(17):e1118-e1120. doi: 10.4244/EIJ-D-24-00355.

DOI:10.4244/EIJ-D-24-00355
PMID:39219359
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11352512/
Abstract
摘要

相似文献

1
A new resorbable magnesium scaffold (DREAMS 3G): 12-month vasomotion results from the BIOMAG-I first-in-human study.一种新型可吸收镁支架（DREAMS 3G）：BIOMAG-I首次人体研究的12个月血管运动结果
EuroIntervention. 2024 Sep 2;20(17):e1118-e1120. doi: 10.4244/EIJ-D-24-00355.
2
Vascular response following implantation of the third-generation drug-eluting resorbable coronary magnesium scaffold: an intravascular imaging analysis of the BIOMAG-I first-in-human study.第三代药物洗脱可吸收冠状动脉镁支架植入后的血管反应：BIOMAG-I 首例人体研究的血管内影像学分析。
EuroIntervention. 2024 Sep 16;20(18):e1173-e1183. doi: 10.4244/EIJ-D-24-00055.
3
Safety and performance of the second-generation drug-eluting absorbable metal scaffold in patients with de-novo coronary artery lesions (BIOSOLVE-II): 6 month results of a prospective, multicentre, non-randomised, first-in-man trial.第二代药物洗脱可吸收金属支架在初发冠状动脉病变患者中的安全性和性能（BIOSOLVE-II）：前瞻性、多中心、非随机、首例人体试验的 6 个月结果。
Lancet. 2016 Jan 2;387(10013):31-9. doi: 10.1016/S0140-6736(15)00447-X. Epub 2015 Oct 12.
4
Serial intracoronary imaging to predict efficacy and safety of magnesium-based resorbable scaffolds.连续冠状动脉内成像预测镁基可吸收支架的疗效和安全性。
EuroIntervention. 2024 Sep 16;20(18):e1124-e1126. doi: 10.4244/EIJ-E-24-00044.
5
A new resorbable magnesium scaffold for de novo coronary lesions (DREAMS 3): one-year results of the BIOMAG-I first-in-human study.用于治疗初次冠状动脉病变的新型可吸收镁支架（DREAMS 3）：BIOMAG-I 首次人体研究的一年结果。
EuroIntervention. 2023 Aug 7;19(5):e414-e422. doi: 10.4244/EIJ-D-23-00326.
6
Dislodgement of a magnesium bioresorbable scaffold from the delivery system in the left main: A true "nightmaris".镁生物可吸收支架在左主干中从输送系统移位：一场真正的“噩梦”。
Cardiol J. 2017;24(6):700-701. doi: 10.5603/CJ.2017.0144.
7
Computed tomography angiography for guiding and follow-up of magnesium-bioresorbable scaffold implantation.计算机断层扫描血管造影术用于指导镁生物可吸收支架植入及随访
Clin Res Cardiol. 2019 Mar;108(3):344-346. doi: 10.1007/s00392-018-1362-8. Epub 2018 Sep 4.
8
Serial 2-dimensional and 3-dimensional optical coherence tomography assessment of overhanging struts of drug-eluting absorbable metal scaffold: "DREAMS" for jailed side branch?药物洗脱可吸收金属支架突出支柱的系列二维和三维光学相干断层扫描评估：“DREAMS”用于被困侧支？
JACC Cardiovasc Interv. 2014 May;7(5):575-6. doi: 10.1016/j.jcin.2013.07.022.
9
Bioresorbable vascular scaffolds in left main coronary artery disease.生物可吸收血管支架在左主干冠状动脉疾病中的应用
EuroIntervention. 2015;11 Suppl V:V135-8. doi: 10.4244/EIJV11SVA30.
10
Design Principles of Bioresorbable Polymeric Scaffolds.可生物降解聚合物支架的设计原理
Interv Cardiol Clin. 2016 Jul;5(3):349-355. doi: 10.1016/j.iccl.2016.02.004. Epub 2016 May 19.

本文引用的文献

1
Bioresorbable Scaffolds: Is There Still Light at the End of the Tunnel?生物可吸收支架：隧道尽头是否仍有曙光？
J Am Coll Cardiol. 2023 Jul 18;82(3):196-199. doi: 10.1016/j.jacc.2023.05.023.
2
A new resorbable magnesium scaffold for de novo coronary lesions (DREAMS 3): one-year results of the BIOMAG-I first-in-human study.用于治疗初次冠状动脉病变的新型可吸收镁支架（DREAMS 3）：BIOMAG-I 首次人体研究的一年结果。
EuroIntervention. 2023 Aug 7;19(5):e414-e422. doi: 10.4244/EIJ-D-23-00326.
3
Structural and Functional Evaluation of Coronary Arteries Treated With ABSORB Bioresorbable Vascular Scaffold at 5-Year Follow-Up.5 年随访时 ABSORB 生物可吸收血管支架治疗的冠状动脉的结构和功能评估。
Am J Cardiol. 2022 Nov 1;182:1-7. doi: 10.1016/j.amjcard.2022.07.038. Epub 2022 Sep 6.
4
Sustained safety and performance of the second-generation drug-eluting absorbable metal scaffold in patients with de novo coronary lesions: 12-month clinical results and angiographic findings of the BIOSOLVE-II first-in-man trial.第二代药物洗脱可吸收金属支架在初发冠状动脉病变患者中的持续安全性和性能：BIOSOLVE-II首次人体试验的12个月临床结果和血管造影结果
Eur Heart J. 2016 Sep 14;37(35):2701-9. doi: 10.1093/eurheartj/ehw196. Epub 2016 May 17.
5
Indication of long-term endothelial dysfunction after sirolimus-eluting stent implantation.西罗莫司洗脱支架植入术后长期内皮功能障碍的指征。
Eur Heart J. 2006 Jan;27(2):166-70. doi: 10.1093/eurheartj/ehi571. Epub 2005 Oct 25.